Arbeitspapier

Biofármacos no Brasil: Características, importância e delineamento de políticas públicas para seu desenvolvimento

The text discusses possibilities of public policies for the development of biopharmaceuticals in Brazil, with emphasis on monoclonal antibodies (mAbs). First section discusses the basic concepts about biotechnology, biopharmaceuticals and monoclonal antibodies in order to sustain the later development of the work. Next, it discusses the evolution of the global pharmaceutical industry, emphasizing biopharmaceuticals, its value chain and general industry challenges. Then, it discusses the Brazilian scenario, emphasizing industry structure, demand, mainly of SUS (Brazilian Health System), regulation and actors involved in the chain or value network. Finalizing the text, a discussion on possibilities and alternatives for the development of public policies that help to leverage the development of this relevant industry.

Language
Portugiesisch

Bibliographic citation
Series: Texto para Discussão ; No. 2398

Classification
Wirtschaft
Technological Change: Government Policy
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Subject
biopharmaceuticals
drug innovation
public policy

Event
Geistige Schöpfung
(who)
Salerno, Mario Sergio
Matsumoto, Cristiane
Ferraz, Isabela
Event
Veröffentlichung
(who)
Instituto de Pesquisa Econômica Aplicada (IPEA)
(where)
Brasília
(when)
2018

Handle
Last update
10.03.2025, 11:44 AM CET

Data provider

This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.

Object type

  • Arbeitspapier

Associated

  • Salerno, Mario Sergio
  • Matsumoto, Cristiane
  • Ferraz, Isabela
  • Instituto de Pesquisa Econômica Aplicada (IPEA)

Time of origin

  • 2018

Other Objects (12)